Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000461639 | SCV000237769 | likely benign | not provided | 2020-07-14 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27066551) |
Ambry Genetics | RCV000249807 | SCV000319715 | likely benign | Cardiovascular phenotype | 2019-09-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000373149 | SCV000342637 | likely benign | not specified | 2016-06-07 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000338023 | SCV000420823 | uncertain significance | Myopathy, myofibrillar, 9, with early respiratory failure | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000397369 | SCV000420824 | uncertain significance | Limb-girdle muscular dystrophy, recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000278867 | SCV000420825 | uncertain significance | Hypertrophic cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000336224 | SCV000420826 | uncertain significance | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000397381 | SCV000420827 | uncertain significance | Early-onset myopathy with fatal cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000315107 | SCV000420828 | uncertain significance | Tibial muscular dystrophy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084202 | SCV000555295 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-29 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000768859 | SCV000900232 | benign | Cardiomyopathy | 2020-06-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000461639 | SCV001152656 | uncertain significance | not provided | 2016-05-01 | criteria provided, single submitter | clinical testing | |
Genetics and Genomics Program, |
RCV001293190 | SCV001434188 | likely benign | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Prevention |
RCV004537559 | SCV004741101 | likely benign | TTN-related disorder | 2024-02-15 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |